One Year Results from the Thoraflex Hybrid US IDE Trial: Breakthrough

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Terumo Aortic

Committed to Aortic Care. Together with our customers, we strive to create effective management of aortic disease and drive the evolution of our cardiovascular solutions for our patients.

This is the official VuMedi channel of Terumo Aortic. It is only intended for medical professionals and is not a substitute for ...
read more ↘ medical advice nor promotion of any medical procedure or product. Please be advised that not all of our products shown on this channel are registered in, approved for sale in, or available for purchase in, all countries or regions where this channel is accessible.
↖ read less

Surgical
Endovascular
Hybrid
Custom Solutions

Playback speed

10 seconds

One Year Results from the Thoraflex Hybrid US IDE Trial: Breakthrough

By Terumo Aortic FEATURING S. Chris Malaisrie

129 views

June 14, 2021

Chris Malaisrie presents on the results of the Thoraflex Hybrid US IDE Trial, including; an overview of worldwide published outcomes, technical experiences from the US IDE trial and the related 30-day outcomes.

The content, discussion and opinions expressed in this video are those of the physician and may not be reflective of the approved indications for use of the device, which may also differ by region. Please consult eifu.terumoaortic.com for product indications, contraindications and warnings/precautions.